Paper35720296
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Furukawa M and 10 others. Front Immunol, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience. Papers, record 35720296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epstein-Barr Virus Infections | Major topic |
| Kidney Transplantation | Major topic |
| Lung Transplantation | Major topic |
| Aged | |
| Alemtuzumab | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Basiliximab | |
| Herpesvirus 4, Human | |
| Humans | |
| Immunosuppressive Agents | |
| Retrospective Studies |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35133655 | Risk factors of bronchial dehiscence after primary lung transplantation. | J Card Surg | 2022 | https://conductscience.org/library/papers/35133655 | PubMed |
| 2 | 31548030 | The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. | J Heart Lung Transplant | 2019 | https://conductscience.org/library/papers/31548030 | PubMed |
| 3 | 25769073 | Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients. | Transplantation | 2015 | https://conductscience.org/library/papers/25769073 | PubMed |
| 4 | 24750290 | To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival. | Clin Transplant | 2014 | https://conductscience.org/library/papers/24750290 | PubMed |
| 5 | 25039364 | Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. | Am J Transplant | 2014 | https://conductscience.org/library/papers/25039364 | PubMed |
| 6 | 26833657 | The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients. | Am J Transplant | 2016 | https://conductscience.org/library/papers/26833657 | PubMed |
| 7 | 30645645 | Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience. | PLoS One | 2019 | https://conductscience.org/library/papers/30645645 | PubMed |
| 8 | 31874120 | Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. | Am J Transplant | 2020 | https://conductscience.org/library/papers/31874120 | PubMed |
| 9 | 34738249 | Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large-scale single-center analysis. | Transpl Int | 2021 | https://conductscience.org/library/papers/34738249 | PubMed |
| 10 | 21420318 | Five-year outcomes with alemtuzumab induction after lung transplantation. | J Heart Lung Transplant | 2011 | https://conductscience.org/library/papers/21420318 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41753126 | Interleukin-2 Receptor Antagonist Induction Therapy in Lung Transplantation-A Meta-Analysis of Reconstructed Time-to-Event Data. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753126 | PubMed |
| 41200160 | Regulatory T cell therapy in lung transplantation: bridging the gap from bench to bedside. | Front Immunol | 2025 | https://conductscience.org/library/papers/41200160 | PubMed |
| 40726985 | Comparative efficacy and safety of induction therapy in solid organ transplantation: a systematic review and network meta-analysis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40726985 | PubMed |
| 40429403 | Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40429403 | PubMed |
| 39642952 | Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort. | J Heart Lung Transplant | 2025 | https://conductscience.org/library/papers/39642952 | PubMed |
| 39551266 | The role of induction therapy in lung transplantation. | Am J Transplant | 2025 | https://conductscience.org/library/papers/39551266 | PubMed |
| 39115489 | Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality. | J Heart Lung Transplant | 2024 | https://conductscience.org/library/papers/39115489 | PubMed |
| 38380332 | Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/38380332 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD52 | 1043 | PubTator's text mining | https://conductscience.org/library/genes/1043 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35720296
GET https://conductscience.org/api/papers/v1/35720296/authors